Enovis (ENOV) Total Liabilities (2010 - 2026)
Enovis' (ENOV) quarterly Total Liabilities came in at $2.3 billion in Q3 2026, down 6.29% year-over-year from $2.4 billion in Q3 2025, and down 2.8% quarter-over-quarter from $2.4 billion in Q2 2026.
Analysis
Enovis (ENOV) Total Liabilities (2010 - 2026) Analysis & Trends
Enovis (ENOV) has reported Total Liabilities for 17 consecutive years, with $2.3 billion the latest figure, recorded in Q3 2026.
- On a quarterly basis, Total Liabilities fell 6.29% year-over-year to $2.3 billion in Q3 2026; TTM through Jul 2026 was $2.3 billion, a 6.29% decrease from a year earlier, with the FY2025 full-year figure at $2.3 billion, up 8.74% from the prior year.
- Total Liabilities was $2.3 billion for Q3 2026 at Enovis, down from $2.4 billion in the prior quarter.
- Over five years, Total Liabilities peaked at $3.8 billion in Q2 2022 and troughed at $823.4 million in Q4 2022.
- A 5-year average of $1.9 billion and a median of $2.2 billion in 2024 frame the typical range for Total Liabilities.
- Across the five-year window, Total Liabilities sank 78.64% in 2022 and jumped 153.75% in 2024, its largest moves.
- Over 5 years, Total Liabilities stood at $823.4 million in 2022, then surged by 32.2% to $1.1 billion in 2023, then soared by 97.9% to $2.2 billion in 2024, then climbed by 8.74% to $2.3 billion in 2025, then retreated by 2.38% to $2.3 billion in 2026.
- The last three Total Liabilities figures came in at $2.3 billion (Q3 2026), $2.4 billion (Q2 2026), and $2.3 billion (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 181.55 Bn | 175.95 Bn | 7.27 Bn | 57.45 Bn |
| 2 | Intuitive Surgical | 127.61 Bn | 122.40 Bn | 1.96 Bn | 2.58 Bn |
| 3 | Medtronic | 117.18 Bn | 108.37 Bn | 6.34 Bn | 42.46 Bn |
| 4 | Stryker | 105.17 Bn | 101.69 Bn | 4.50 Bn | 23.94 Bn |
| 5 | Boston Scientific | 64.67 Bn | 64.13 Bn | 3.85 Bn | 20.04 Bn |
| 6 | Edwards Lifesciences | 49.86 Bn | 45.61 Bn | 1.35 Bn | 3.14 Bn |
| 7 | Alcon | 33.06 Bn | 31.60 Bn | 1.68 Bn | 9.50 Bn |
| 8 | Dexcom | 32.22 Bn | 30.27 Bn | 830.00 Mn | 3.83 Bn |
| 9 | Steris | 20.74 Bn | 20.26 Bn | 684.20 Mn | 3.51 Bn |
| 10 | Enovis | 1.08 Bn | 1.07 Bn | 359.25 Mn | 2.29 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jul 3, 2026 | 2.29 Bn |
| Apr 3, 2026 | 2.35 Bn |
| Dec 31, 2025 | 2.34 Bn |
| Oct 3, 2025 | 2.41 Bn |
| Jul 4, 2025 | 2.44 Bn |
| Apr 4, 2025 | 2.25 Bn |
| Dec 31, 2024 | 2.15 Bn |
| Sep 27, 2024 | 2.22 Bn |
| Jun 28, 2024 | 2.15 Bn |
| Mar 29, 2024 | 2.17 Bn |
| Dec 31, 2023 | 1.09 Bn |
| Sep 29, 2023 | 959.19 Mn |
| Jun 30, 2023 | 992.79 Mn |
| Mar 31, 2023 | 854.32 Mn |
| Dec 31, 2022 | 823.45 Mn |
| Sep 30, 2022 | 1.04 Bn |
| Jul 1, 2022 | 1.01 Bn |
| Apr 1, 2022 | 3.84 Bn |
| Dec 31, 2021 | 3.85 Bn |
| Oct 1, 2021 | 3.34 Bn |